Pancreaze DR 37,000 unit cap 50S
Ended Awarded Last action
- Contract number
- SPE2DR26FJF8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,424
Award facts
- Contract value 100% obligated
- $41,424.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 37,000 units of Pancreaze in 50-count capsule format, with a ceiling value of $41,424.05. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems.
Pancreaze is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, making this procurement part of the DLA's broader medical supply chain supporting military personnel, veterans, and other federal healthcare beneficiaries. AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills federal medical procurement requirements across multiple therapeutic domains through its extensive portfolio of brand-name and generic medications. The competitively awarded nature of this delivery order reflects the contractor's demonstrated capability to meet federal procurement standards and deliver critical pharmaceutical commodities to support military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FJF8M?
SPE2DR26FJF8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FJF8M worth?
The government has obligated $41,424 on SPE2DR26FJF8M.
Is contract SPE2DR26FJF8M an order under another contract?
Yes. SPE2DR26FJF8M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF8M competed?
The extent of competition for SPE2DR26FJF8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award